These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 38886098)
1. Digestive dynamics: Unveiling interplay between the gut microbiota and the liver in macronutrient metabolism and hepatic metabolic health. Kandalgaonkar MR; Kumar V; Vijay-Kumar M Physiol Rep; 2024 Jun; 12(12):e16114. PubMed ID: 38886098 [TBL] [Abstract][Full Text] [Related]
2. Dietary lipids, gut microbiota and lipid metabolism. Schoeler M; Caesar R Rev Endocr Metab Disord; 2019 Dec; 20(4):461-472. PubMed ID: 31707624 [TBL] [Abstract][Full Text] [Related]
3. The Role of the Gut Microbiota in Bile Acid Metabolism. Ramírez-Pérez O; Cruz-Ramón V; Chinchilla-López P; Méndez-Sánchez N Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s15-s20. PubMed ID: 29080339 [TBL] [Abstract][Full Text] [Related]
4. The gut bacterium Streidl T; Karkossa I; Segura Muñoz RR; Eberl C; Zaufel A; Plagge J; Schmaltz R; Schubert K; Basic M; Schneider KM; Afify M; Trautwein C; Tolba R; Stecher B; Doden HL; Ridlon JM; Ecker J; Moustafa T; von Bergen M; Ramer-Tait AE; Clavel T Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33382950 [No Abstract] [Full Text] [Related]
5. Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota. Ohtani N; Hara E Cancer Sci; 2021 Nov; 112(11):4433-4443. PubMed ID: 34533882 [TBL] [Abstract][Full Text] [Related]
6. The role of gut microbiota in liver regeneration. Xu Z; Jiang N; Xiao Y; Yuan K; Wang Z Front Immunol; 2022; 13():1003376. PubMed ID: 36389782 [TBL] [Abstract][Full Text] [Related]
7. Chronic sucralose consumption inhibits farnesoid X receptor signaling and perturbs lipid and cholesterol homeostasis in the mouse livers, potentially by altering gut microbiota functions. Chi L; YifeiYang ; Bian X; Gao B; Tu P; Ru H; Lu K Sci Total Environ; 2024 Apr; 919():169603. PubMed ID: 38272087 [TBL] [Abstract][Full Text] [Related]
8. Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver-Gut Axis. Grüner N; Mattner J Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573273 [TBL] [Abstract][Full Text] [Related]
9. Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism. Wahlström A; Sayin SI; Marschall HU; Bäckhed F Cell Metab; 2016 Jul; 24(1):41-50. PubMed ID: 27320064 [TBL] [Abstract][Full Text] [Related]
10. Improvements in estrogen deficiency-induced hypercholesterolemia by Hypericum perforatum L. extract are associated with gut microbiota and related metabolites in ovariectomized (OVX) rats. Chen L; Liu Y; Tang Z; Shi X; Song Z; Cao F; Wei P; Li M; Li X; Jiang D; Yan Y; Yang N Biomed Pharmacother; 2021 Mar; 135():111131. PubMed ID: 33383372 [TBL] [Abstract][Full Text] [Related]
11. Impact of cholecystectomy on the gut-liver axis and metabolic disorders. Amaral Raposo M; Sousa Oliveira E; Dos Santos A; Guadagnini D; El Mourabit H; Housset C; Lemoinne S; Abdalla Saad MJ Clin Res Hepatol Gastroenterol; 2024 Aug; 48(7):102370. PubMed ID: 38729564 [TBL] [Abstract][Full Text] [Related]
12. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Agus A; Clément K; Sokol H Gut; 2021 Jun; 70(6):1174-1182. PubMed ID: 33272977 [TBL] [Abstract][Full Text] [Related]
13. The Gut Microbial Bile Acid Modulation and Its Relevance to Digestive Health and Diseases. Fogelson KA; Dorrestein PC; Zarrinpar A; Knight R Gastroenterology; 2023 Jun; 164(7):1069-1085. PubMed ID: 36841488 [TBL] [Abstract][Full Text] [Related]
14. Interactions between gut bacteria and bile in health and disease. Long SL; Gahan CGM; Joyce SA Mol Aspects Med; 2017 Aug; 56():54-65. PubMed ID: 28602676 [TBL] [Abstract][Full Text] [Related]
15. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota. Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804 [TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota-Derived Components and Metabolites in the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD). Ji Y; Yin Y; Li Z; Zhang W Nutrients; 2019 Jul; 11(8):. PubMed ID: 31349604 [TBL] [Abstract][Full Text] [Related]
17. Exploring the role of a novel postbiotic bile acid: Interplay with gut microbiota, modulation of the farnesoid X receptor, and prospects for clinical translation. Wang B; Han D; Hu X; Chen J; Liu Y; Wu J Microbiol Res; 2024 Oct; 287():127865. PubMed ID: 39121702 [TBL] [Abstract][Full Text] [Related]
18. Gut microbiota and metabolites of cirrhotic portal hypertension: a novel target on the therapeutic regulation. Hao Y; Hao Z; Zeng X; Lin Y J Gastroenterol; 2024 Sep; 59(9):788-797. PubMed ID: 39028343 [TBL] [Abstract][Full Text] [Related]
19. Gut-microbiota derived bioactive metabolites and their functions in host physiology. Debnath N; Kumar R; Kumar A; Mehta PK; Yadav AK Biotechnol Genet Eng Rev; 2021 Oct; 37(2):105-153. PubMed ID: 34678130 [TBL] [Abstract][Full Text] [Related]
20. Gut microbiota and host metabolism in liver cirrhosis. Usami M; Miyoshi M; Yamashita H World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]